The votes in favor of Merck's shot are a sigh of relief after Kennedy gutted the panel and tapped replacements, some of whom are well-known vaccine critics.

Merck's Enflonsia vaccine for respiratory syncytial virus won approval from the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices.

A group of outside advisers to the US Centers for Disease Control and Prevention voted 5-2 to recommend use of a new shot that can protect babies from respiratory syncytial virus, adding an additional ...

The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...

Kennedy selected a new team of medical professionals and scientists who are looking at vaccines are highly qualified.

Robert F. Kennedy Jr. had fired all 17 members of a key vaccine panel. Now his new panel recommended a new infant RSV vaccine. What to know.

The votes on vaccine recommendations are the first move by the panel after Health and Human Services Secretary Robert F.

A CDC advisory panel on Thursday voted 5-2 to recommend the use of a new preventative RSV therapy in babies, Merck’s Enflonsia.

Kennedy’s controversial panel overhaul met its first test. The result? A major win for public health ahead of RSV season.

A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially deadly RSV.

Enjoy, and see you soon… A fast-growing group of Americans is turning to what many call the “gray market” for obesity medicines, bringing cheap active ingredients from China often labeled as for ...

However, ACIP recommendations are tremendously influential in how vaccines are used in the US, with implications for insurance coverage and state policies. Advisers endorse Merck RSV antibody ...